日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The landscape of responses to neoadjuvant immunotherapy in resectable Kirsten rat sarcoma viral oncogene homolog-mutant lung adenocarcinoma: Clinical heterogeneity and correlative immunologic analysis

可切除的Kirsten鼠肉瘤病毒癌基因同源物突变型肺腺癌新辅助免疫治疗反应的概况:临床异质性和相关免疫学分析

Wu, Sikai; Niu, Jiheng; Chen, Xiaowei; Li, Jinfei; Tang, Quanying; Yang, Zhenlin; Gao, Shugeng

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study

来自 KEYNOTE-671 随机研究的围手术期帕博利珠单抗治疗 II 期非小细胞肺癌的亚组分析

Tsuboi, Masahiro; Wakelee, Heather; Garassino, Marina C; Gao, Shugeng; Luft, Alexander; Chen, Ke-Neng; Spicer, Jonathan D; Zhu, Yuming; Saji, Hisashi; Okada, Morihito; Vanakesa, Tõnu; Chen, Haiquan; Zhao, Guofang; Ikeda, Norihiko; Jones, David R; Weksler, Benny; Huang, Chien-Sheng; Jensen, Erin; Keller, Steven M; Samkari, Ayman; Liberman, Moishe

Single-cell RNA sequencing and spatial transcriptomics of esophageal squamous cell carcinoma with lymph node metastases

食管鳞状细胞癌淋巴结转移的单细胞RNA测序和空间转录组学

Guo, Wei; Zhou, Bolun; Dou, Lizhou; Guo, Lei; Li, Yong; Qin, Jianjun; Wang, Zhen; Huai, Qilin; Xue, Xuemin; Li, Yin; Ying, Jianming; Xue, Qi; Gao, Shugeng; He, Jie

Cell Death and Senescence-Based Molecular Classification and an Individualized Prediction Model for Lung Adenocarcinoma.

基于细胞死亡和衰老的分子分型及肺腺癌个体化预测模型

Wang Pan, Zhang Chaoqi, Wu Peng, Zhao Zhihong, Sun Nan, Xue Qi, Gao Shugeng, He Jie

Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: a phase 2 clinical trial

采用白蛋白结合型紫杉醇联合顺铂和卡培他滨进行新辅助化疗治疗局部晚期食管鳞状细胞癌:一项 II 期临床试验

Zhang, Wen; Chen, Xiaowei; Xue, Liyan; Jiang, Zhichao; Qu, Dong; Yang, Zhaoyang; Qin, Jianjun; Wang, Zhen; Zhang, Miaomiao; Li, Yong; Zhou, Aiping; Gao, Shugeng

Assessing the global burden of mesothelioma: trends, socioeconomic influences, and asbestos exposure - a retrospective cohort study

评估间皮瘤的全球负担:趋势、社会经济影响和石棉暴露——一项回顾性队列研究

Zhao, Ziran; Li, Jiagen; Tan, Fengwei; Xue, Qi; Gao, Shugeng; He, Jie

Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trial

完全切除和辅助化疗(PORT-C)后接受术后放疗的pIIIA-N2期非小细胞肺癌患者的长期疗效:一项单中心、随机、3期试验

Men, Yu; Bao, Yongxing; Bi, Nan; Zhou, Zongmei; Liang, Jun; Lv, Jima; Feng, Qinfu; Xiao, Zefen; Wang, Yan; Li, Junling; Wang, Jie; Gao, Shugeng; He, Jie; Hui, Zhouguang; Wang, Luhua

Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503)

胸段食管鳞状细胞癌患者三野淋巴结清扫术与两野淋巴结清扫术:一项多中心随机研究(NST 1503)

Mao, Yousheng; Liu, Shuoyan; Han, Yongtao; Guo, Shiping; Chen, Chun; Gao, Shugeng; Hao, Anlin; Duan, Hongbing; Fang, Wentao; Zhang, Renquan; Yu, Zhentao; Fu, Xiangning; Li, Xiaofei; Wang, Qun; Tan, Lijie; Li, Zhigang; Li, Yin; Zhang, Zhirong; Wei, Wenqiang; Fang, Yan; Fu, Donghong; Wei, Xudong; Yuan, Ligong; Muhammad, Shan; He, Jie

Real-world long-term outcomes of non-small cell lung cancer patients undergoing neoadjuvant treatment with or without immune checkpoint inhibitors

非小细胞肺癌患者接受新辅助治疗(含或不含免疫检查点抑制剂)的真实世界长期疗效

Zhou, Bolun; Li, Lin; Zhang, Fan; Huai, Qilin; Zhao, Liang; Tan, Fengwei; Xue, Qi; Guo, Wei; Gao, Shugeng

Clinical practice guidelines for perioperative multimodality treatment of non-small cell lung cancer

非小细胞肺癌围手术期多模式治疗的临床实践指南

Jiao, Wenjie; Zhao, Liang; Mei, Jiandong; Zhong, Jia; Yu, Yongfeng; Bi, Nan; Zhang, Lan; Wang, Lvhua; Fu, Xiaolong; Wang, Jie; Lu, Shun; Liu, Lunxu; Gao, Shugeng